Coronary thrombolysis with tissue-type plasminogen activator: prospective review
Related Experiment Video
Updated: Aug 23, 2026

Prehospital Thrombolysis: A Manual from Berlin
Published on: November 26, 2013
1Center for Thrombosis and Vascular Research, Department of Medical Research, University of Leuven, Belgium.
Insights
Coronary thrombolysis aims to prevent heart muscle cell death in acute myocardial infarction. Studies show thrombolytic agents effectively reopen blocked coronary arteries in most patients and animal models.
Area of Science:
- Cardiology
- Vascular Medicine
- Pharmacology
Background:
- Acute myocardial infarction (AMI) involves thrombotic occlusion of coronary arteries.
- Myocardial cell necrosis leads to impaired cardiac function.
- Coronary thrombolysis is a therapeutic strategy to restore blood flow.
Purpose of the Study:
- To review the role of coronary thrombolysis in preventing myocardial cell dysfunction.
- To summarize current research on thrombolytic therapy for AMI.
- To evaluate the efficacy of thrombolytic agents in reopening occluded coronary arteries.
Main Methods:
- Review of existing studies on coronary thrombolysis.
- Analysis of data from animal models of myocardial infarction.
- Examination of clinical trial results in human patients with AMI.
Main Results:
- Thrombolytic agents successfully reopen occluded coronary arteries in a majority of AMI cases.
- Studies in animal models demonstrate the protective effects of thrombolysis.
- Clinical investigations confirm the benefit of thrombolysis in patients.
Conclusions:
- Coronary thrombolysis is a critical intervention for AMI, aimed at salvaging myocardial tissue.
- The effectiveness of thrombolytic agents in restoring coronary patency is well-established.
- Ongoing research continues to refine the application of thrombolysis in cardiovascular medicine.
Abstract:
Coronary thrombolysis is not a goal in itself, but is employed to prevent necrotic dysfunction of jeopardized myocardial cells. It is being increasingly investigated as a treatment for acute myocardial infarction, which is often associated with thrombotic occlusion of an atherosclerotic coronary artery. The administration of thrombolytic agents has been shown to reopen an occluded coronary artery in the majority of such cases. Briefly summarized are studies performed to date in animal models and in patients with acute myocardial infarction.
Related Concept Videos
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
Venous Thrombosis III: Interprofessional Care
Peripheral Artery Disease III: Interprofessional Care
Acute Coronary Syndrome I: Introduction
Clot Retraction and Fibrinolysis
